Learn languages naturally with fresh, real content!

Popular Topics
Explore By Region
Applied DNA Sciences shifts focus to genetic medicines, selling assets and cutting costs.
Applied DNA Sciences has announced a strategic shift to focus on producing essential materials for genetic medicines.
The company plans to sell its CertainT platform, reduce operating expenses by 15%, and keep Applied DNA Clinical Labs for its profitable pharmacogenomic testing services.
The completion of its GMP manufacturing facility is expected by January 9, 2025, with potential annual revenue of $4 million to $16 million.
5 Articles
Las Ciencias del ADN aplicadas se centran en las medicinas genéticas, la venta de activos y la reducción de costos.